Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
R Cherniak
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Genes & Molecular Sequences
Phenomena
Concepts & Ideas
Procedures
Anatomy
Sign-in to see full Profile
Network (preview)
8
Morris, Laura
5
Vaishnav, VV
4
Sheng, S
4
Verheul, AF
3
Verhoef, Jan
3
Van Halbeek, H
3
Scharringa, Jelle
3
Snippe, Harm
3
Chaka, Wendy
3
Coenjaerts, Frank
3
Hoepelman, Andy
3
Jacobson, Eric
2
Kozel, Thomas
2
Hoepelman, IM
2
Casadevall, Arturo
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of R Cherniak (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2001: Coenjaerts F E; Walenkamp A M; Mwinzi P N; Scharringa J; Dekker H A; van Strijp J A; Cherniak R; Hoepelman A I
Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(7):3988-95.
-
2000: Lipovsky M M; Tsenova L; Coenjaerts F E; Kaplan G; Cherniak R; Hoepelman A I
Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood-brain barrier in an animal model of acute bacterial meningitis.
Journal of neuroimmunology 2000;111(1-2):10-4.
-
1999: Walenkamp A M; Chaka W S; Verheul A F; Vaishnav V V; Cherniak R; Coenjaerts F E; Hoepelman I M
Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structure.
FEMS immunology and medical microbiology 1999;26(3-4):309-18.
-
1998: Cherniak R; O'Neill E B; Sheng S
Assimilation of xylose, mannose, and mannitol for synthesis of glucuronoxylomannan of Cryptococcus neoformans determined by 13C nuclear magnetic resonance spectroscopy.
Infection and immunity 1998;66(6):2996-8.
-
1998: Cherniak R; Valafar H; Morris L C; Valafar F
Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network.
Clinical and diagnostic laboratory immunology 1998;5(2):146-59.
-
1998: Sheng S; Cherniak R; van Halbeek H
A 1H NMR spectroscopic approach to the unambiguous determination of glycosyl linkage positions in oligosaccharides.
Analytical biochemistry 1998;256(1):63-6.
-
1998: Vaishnav V V; Bacon B E; O'Neill M; Cherniak R
Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67.
Carbohydrate research 1998;306(1-2):315-30.
-
1997: Sheng S; Cherniak R
Structure of the capsular polysaccharide of Clostridium perfringens Hobbs 10 determined by NMR spectroscopy.
Carbohydrate research 1997;305(1):65-72.
-
1997: Chaka W; Verheul A F; Vaishnav V V; Cherniak R; Scharringa J; Verhoef J; Snippe H; Hoepelman A I
Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):2979-85.
-
1997: Sheng S; Cherniak R
Structure of the 13C-enriched O-deacetylated glucuronoxylomannan of Cryptococcus neoformans serotype A determined by NMR spectroscopy.
Carbohydrate research 1997;301(1-2):33-40.
-
1997: Chang Y C; Cherniak R; Kozel T R; Granger D L; Morris L C; Weinhold L C; Kwon-Chung K J
Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 gene.
Infection and immunity 1997;65(5):1584-92.
-
1997: Kalelkar S; Glushka J; van Halbeek H; Morris L C; Cherniak R
Structure of the capsular polysaccharide of Clostridium perfringens Hobbs 5 as determined by NMR spectroscopy.
Carbohydrate research 1997;299(3):119-28.
-
1997: Orendi J M; Verheul A F; De Vos N M; Visser M R; Snippe H; Cherniak R; Vaishnav V V; Rijkers G T; Verhoef J
Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication.
Clinical and experimental immunology 1997;107(2):293-9.
-
1997: Belay T; Cherniak R; Kozel T R; Casadevall A
Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay.
Infection and immunity 1997;65(2):718-28.
-
1997: Chaka W; Verheul A F; Vaishnav V V; Cherniak R; Scharringa J; Verhoef J; Snippe H; Hoepelman I M
Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells.
Infection and immunity 1997;65(1):272-8.
-
1996: Bacon B E; Cherniak R; Kwon-Chung K J; Jacobson E S
Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy.
Carbohydrate research 1996;283():95-110.
-
1996: Belay T; Cherniak R; O'Neill E B; Kozel T R
Serotyping of Cryptococcus neoformans by dot enzyme assay.
Journal of clinical microbiology 1996;34(2):466-70.
-
1995: Bacon B E; Cherniak R
Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype C as determined by 2D 1H NMR spectroscopy.
Carbohydrate research 1995;276(2):365-86.
-
1995: Cherniak R; Morris L C; Belay T; Spitzer E D; Casadevall A
Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis.
Infection and immunity 1995;63(5):1899-905.
-
1995: Belay T; Cherniak R
Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.
Infection and immunity 1995;63(5):1810-9.
-
1994: Cherniak R; Sundstrom J B
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
Infection and immunity 1994;62(5):1507-12.
-
1993: Cherniak R; Morris L C; Meyer S A; Mitchell T B
Glucuronoxylomannan of Cryptococcus neoformans obtained from patients with AIDS.
Carbohydrate research 1993;249(2):405-13.
-
1993: Belay T; Cherniak R; Shinoda T
Specificity of Cryptococcus neoformans factor sera determined by enzyme-linked immunosorbent assay and dot enzyme assay.
Infection and immunity 1993;61(7):2879-85.
-
1993: Sundstrom J B; Cherniak R
T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A.
Infection and immunity 1993;61(4):1340-5.
-
1992: Sundstrom J B; Cherniak R
The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen.
Infection and immunity 1992;60(10):4080-7.
-
1992: Turner S H; Cherniak R; Reiss E; Kwon-Chung K J
Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy.
Carbohydrate research 1992;233():205-18.
-
1992: Cherniak R; Morris L C; Meyer S A
Glucuronoxylomannan of Cryptococcus neoformans serotype C: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.
Carbohydrate research 1992;225(2):331-7.
-
1992: James P G; Cherniak R
Galactoxylomannans of Cryptococcus neoformans.
Infection and immunity 1992;60(3):1084-8.
-
1992: Cherniak R; Morris L C; Turner S H
Glucuronoxylomannan of Cryptococcus neoformans serotype D: structural analysis by gas-liquid chromatography-mass spectrometry and by 13C-nuclear magnetic resonance spectroscopy.
Carbohydrate research 1992;223():263-9.
-
1991: Skelton M A; van Halbeek H; Cherniak R
Complete assignment of the 1H- and 13C-n.m.r. spectra of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype B.
Carbohydrate research 1991;221():259-68.
-
1991: Turner S H; Cherniak R
Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.
Carbohydrate research 1991;211(1):103-16.
-
1991: Cherniak R; Morris L C; Anderson B C; Meyer S A
Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans.
Infection and immunity 1991;59(1):59-64.
-
1990: Stortz C A; Cherniak R; Jones R G; Treber T D; Reinhardt D J
Polysaccharides from Peptostreptococcus anaerobius and structure of the species-specific antigen.
Carbohydrate research 1990;207(1):101-20.
-
1990: James P G; Cherniak R
4-Methylmorpholine N-oxide-methyl sulfoxide soluble glucan of Piptoporus betulinus.
Carbohydrate research 1990;206(1):167-72.
-
1990: James P G; Cherniak R; Jones R G; Stortz C A; Reiss E
Cell-wall glucans of Cryptococcus neoformans Cap 67.
Carbohydrate research 1990;198(1):23-38.
-
1990: White C W; Cherniak R; Jacobson E S
Side group addition by xylosyltransferase and glucuronyltransferase in biosynthesis of capsular polysaccharide in Cryptococcus neoformans.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1990;28(4):289-301.
-
1989: Vartivarian S E; Reyes G H; Jacobson E S; James P G; Cherniak R; Mumaw V R; Tingler M J
Localization of mannoprotein in Cryptococcus neoformans.
Journal of bacteriology 1989;171(12):6850-2.
-
1989: Todaro-Luck F; Reiss E; Cherniak R; Kaufman L
Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.
Infection and immunity 1989;57(12):3882-7.
-
1989: Todaro-Luck F; White E H; Reiss E; Cherniak R
Immunoelectronmicroscopic characterization of monoclonal antibodies (MAbs) against Cryptococcus neoformans.
Molecular and cellular probes 1989;3(4):345-61.
-
1988: Cherniak R; Jones R G; Slodki M E
Type-specific polysaccharides of Cryptococcus neoformans. n.m.r.-spectral study of a glucuronomannan chemically derived from a Tremella mesenterica exopolysaccharide.
Carbohydrate research 1988;182(2):227-39.
-
1988: Murphy J W; Mosley R L; Cherniak R; Reyes G H; Kozel T R; Reiss E
Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens.
Infection and immunity 1988;56(2):424-31.
-
1988: Cherniak R; Jones R G; Reiss E
Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy.
Carbohydrate research 1988;172(1):113-38.
-
1988: Cherniak R; Cheeseman M M; Reyes G H; Reiss E; Todaro F
Enhanced binding of capsular polysaccharides of Cryptococcus neoformans to polystyrene microtitration plates for enzyme-linked immunosorbent assay.
Diagnostic and clinical immunology 1988;5(6):344-8.
-
1986: Reiss E; White E H; Cherniak R; Dix J E
Ultrastructure of acapsular mutant Cryptococcus neoformans cap 67 and monosaccharide composition of cell extracts.
Mycopathologia 1986;93(1):45-54.
-
1985: Reiss E; Huppert M; Cherniak R
Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes.
Current topics in medical mycology 1985;1():172-207.
-
1984: Turner S H; Cherniak R; Reiss E
Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans.
Carbohydrate research 1984;125(2):343-9.
-
1984: Reiss E; Cherniak R; Eby R; Kaufman L
Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans.
Diagnostic immunology 1984;2(2):109-15.
-
1980: Kozel T R; Reiss E; Cherniak R
Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide.
Infection and immunity 1980;29(2):295-300.
-
1980: Cherniak R; Reiss E; Slodki M E; Plattner R D; Blumer S O
Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A.
Molecular immunology 1980;17(8):1025-32.
Sign-in to see more